Cancer Institute A national cancer institute
designated cancer center

February 2010 Funding Opportunities

St. Baldrick's Foundation (pediatric cancer)
Deadlines for all:
Letter of intent:  Feb. 5, 2010
Applications: March 31, 2010

St. Baldrick’s Fellows: The Foundation funds years 2-3 of a pediatric oncology research fellowship, with an opportunity for one additional year of funding. This career development award is to help develop the independent research of highly qualified individuals still early in their careers. ($110,000/year, 3-year minimum, with an opportunity for two additional years. Funding is for Scholar’s salary & benefits only.)

Research grants: These one-year grants are for specific research projects which are hypothesis driven and may be either laboratory or clinical in nature. (Please submit a realistic budget for the project; average grant will be $100,000 or less.)
Supportive Care Research grants: These grants are for specific research projects that are hypothesis driven and focus on areas related to the supportive care of children and adolescents with cancer.
Examples include but are not limited to: studies related to symptom clusters, patient-reported outcomes/quality of life, health communication, health promotion and psychosocial support across the trajectory from diagnosis to survivorship or end-of-life care. (Please submit a realistic budget for the project; average grant will be $50,000).

To download the program guidelines for each of the above RFAs, please go to proposalCENTRAL and click on the document icon opposite the name of the specific St. Baldrick's Foundation RFA. https://proposalcentral.altum.com/
For information on the foundation (note: the program guidelines are only available via proposalcentral): http://www.stbaldricks.org/

American Association for the Study of Liver Diseases
AASLD Clinical and Translational Research Awards (assist. professors)
Deadline:  Feb. 12, 2010
http://www.aasld.org/research/awards/Pages/ClinicalandTranslationalResearchAwards.aspx <http://www.aasld.org/research/awards/Pages/ClinicalandTranslationalResearchAwards.aspx>

Children's Tumor Foundation  (neurofibromatosis)
Young Investigator Award (junior faculty and postdoctoral fellows)
Pre-application: Feb. 5, 2010
 Full application: March 5, 2010
http://www.ctf.org/For-Scientists/young-investigator-awards.html <http://www.ctf.org/For-Scientists/young-investigator-awards.html>

The Leukemia and Lymphoma Society
Translational Research Program  $200K total over 3 yrs
Deadline LOI (required):  March 1, 2010
Full application:  March 15, 2010
http://www.leukemia-lymphoma.org/all_page?item_id=11620

Hope Street Kids
Grants for junior faculty development in pediatric cancer research ($40K/yr x 2 yrs)
Pediatric Cancer Research Fellowship [postdocs: submit via the Fellowship Office: http://med.stanford.edu/rmg/fellowships.html ]
Deadline:  March 1, 2010  via proposal central -see instructions at the end of this message)
http://www.hopestreetkids.org/grants_research/applications.php


The Fiscal Year (FY) Department of Defense 2010 Appropriation included $80 million for the Prostate Cancer Research Program (PCRP).

New for FY10: PCRP Overarching Challenges
The overarching goals of the FY10 program are aimed towards eliminating death and suffering from prostate cancer.  All applications for the PCRP Exploration-Hypothesis Development Award and Impact Award should address at least one of these overarching challenges:
Develop effective treatments for advanced prostate cancer
Distinguish lethal from indolent disease
 
Applications for the PCRP Exploration-Hypothesis Development and Impact Awards should also address at least one of the following FY10 PCRP focus areas (revised for FY2010):
1.   Biomarkers: Discovery and validation of biomarkers for the detection, prognosis, and progression of prostate cancer.
2.   Genetics: Understanding the genetics and epigenetics responsible for susceptibility, disease progression and treatment outcomes for clinically significant prostate cancer.
3.   Imaging: Development of new imaging technology for the detection and prognosis of prostate cancer, including progression to systemic disease.
4.   Survivorship: Studies on the impact of treatment, nutrition, metabolism and exercise on the well being of prostate cancer patients and their families.
5.   Therapy: Identification of new targets, pathways and therapeutic modalities or molecules for the treatment of prostate cancer.
6.   Tumor Biology: Understanding the heterogeneity and microenvironment for the prognosis and progression of prostate cancer.

Award mechanisms: two just announced, two previously announced:

1) PCRP Exploration-Hypothesis Award:
Purpose:
supports the exploration of highly innovative, untested, high-risk/high-gain concepts, theories, paradigms and/or methods
that address an important problem in prostate cancer. Results of studies conducted through this award may provide the scientific rationale upon which a new hypothesis can be based, or
initial proof-of-principle of an innovative hypothesis. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new
avenues for investigation. Presentation of preliminary data is not allowed. However, logical reasoning and a sound scientific rationale for the proposed work must be provided.
Interesting features of the PCRP Exploration-Hypothesis Development Award include:  emphasis on innovation, preliminary data not allowed, no clinical trials, reviewers will be blinded to
the identity of the PI, collaborators, and their organizations, Application Project Narrative limited to 1 page.  
Eligibility:  Stanford faculty with PI eligibility;
Special note: even though the guidelines states that it is open to post-docs and above, because this is a research grant, Stanford policy only permits Stanford faculty with PI eligibility to
apply)
Amount of funding: Maximum funding of $75,000 for direct costs plus indirect costs, for a period of performance of up to one (1) year.
Deadlines:
Pre-Application (Letter of Intent) through http://cdmrp.org <http://cdmrp.org> required and due: March 10, 2010; 5:00 p.m. Eastern Time.
Application through due March 31, 2010, 11:59pm EST via grants.gov

2) PCRP Impact Award
Purpose: This award will support research projects specifically focused on making a major impact on one critical issue in prostate cancer:  reducing or eliminating the over-treatment of
primary prostate cancer.  Principal Investigators (PIs) applying for the Impact Award are expected to establish a multi-disciplinary study team that may include a variety of clinical specialists
to effectively address the proposed question.  Projects funded by this award will, if successful, ultimately change the standard of practice for decision-making in the treatment of primary
prostate cancer.
Interesting features of the Prostate Cancer Impact Award include: clinical trials allowed, emphasis on impact, must include preliminary data from laboratory of PI or member(s) of research
team to support feasibility of study,
Eligibility: Stanford faculty with PI eligibility
Amount of funding: maximum funding of $750,000 for direct costs plus indirect costs, for a period of performance of up to four (4) years.
Deadlines:
Pre-Application through http://cdmrp.org <http://cdmrp.org> required and due: March 17, 2010; 5:00 p.m. Eastern Time.
Pre-proposals (Pre-proposal narrative has a 2 page limit) and will be screened by peer review and submission of full application is by PCRP invitation).
Invitations from the PCRP to selected pre-applicants: April 19, 2010
Application due June 9, 2010, 11:59 pm EST via grants.gov

3) Idea Development Award
Purpose
: The PCRP Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to eliminating death and suffering from prostate cancer. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. The PCRP seeks applications from the wide spectrum of basic to clinical research (excluding clinical trials), that are responsive to at least one of the PCRP overarching challenges and at least one of the PCRP focus areas.
See the program guidelines for 2010 research focus areas.
Amount of funding: maximum funding of $450,000 in direct costs (plus indirects) for up to 3 years
Eligibility:  Stanford faculty with PI eligibility
Deadlines:
Pre-application:  March 3, 2010,  5 pm EST via the CDMRP eReceipt system
Invitation to Submit an Application: April 21, 2010
Full application (by invitation only):  June 9, 2010 11:59 p.m. EST  via grants.gov

4)  Synergistic Idea Development Award
Purpose:
The PCRP Synergistic Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research involving two or three independent, faculty-level (or equivalent) Principal Investigators (PIs). These investigators should use synergistic and complementary perspectives to address a central problem or question in prostate cancer research. This award is designed to encourage and support both new and pre-existing partnerships. The overall goal of this award is to significantly accelerate advances in prostate cancer research to support the PCRP vision of conquering prostate cancer. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature.  The Synergistic Idea Development Award requires that multiple investigators jointly design a single project. However, each partner will be recognized as a PI, submit a separate application, and receive an individual award. The research project must be supported by the unique expertise of each PI, and it must clearly define the synergistic components that will facilitate and accelerate progress in a way that could not be accomplished through independent efforts. Multidisciplinary projects are encouraged, and multi-institutional projects are allowed.
See the program guidelines for 2010 research focus areas.
Amount of funding: maximum funding of $750,000 in direct costs (plus indirects) for up to 3 years
Eligibility:  Stanford faculty with PI eligibility
Deadlines:
Pre-application:  March 3, 2010, 5 pm EST via the CDMRP eReceipt system
Invitation to Submit an Application: April 21, 2010
Full application (by invitation only):  June 9, 2010 11:59 p.m. EST via grants.gov

CanLiv - The Hepatocellular Cancers Foundation
Young Investigators Awards for Translational Research
Deadline: March 5, 2010

CanLiv - The Hepatobiliary Cancers Foundation, which works to improve the lives of individuals diagnosed with cancer of the bile ducts, gallbladder and liver, is accepting applications for its Young Investigators Awards for Translational Research program.

The total award amount is $30,000 for one year.

The award provides funding to promising new investigators to encourage and promote translational research in cancers of the gallbladder and/or bile ducts (cholangiocarcinoma).
Applicants must hold an MD, DO, PhD or DSci degree and be in their first-to-third year of a full-time, primary faculty appointment in a clinical, basic or translational science department at an academic medical institution. For foreign-trained physicians or scientists, equivalency will be determined on a case-by-case basis.

Applicants must be tenure-track scientists at the level of assistant professor and must have completed a productive period of post-doctoral research, with demonstrated ability to undertake independent investigator-initiated research. There are no citizenship requirements.

Contact: Complete RFP

James S. McDonnell Foundation
Studying Complex Systems or Brain Cancer Research
21st Century Science Inititative: Research Awards-up to $450,000 for up to 6 year
Deadline:  March 17, 2010
http://www.jsmf.org/apply/apply.php

The Sontag Foundation
Distinguished Scientist Award
(brain cancer research)
Assist. professors
Each Award consists of a four-year funding component totaling a maximum of $600,000. (3 to be awarded.)
Deadline:  March 24, 2010
http://www.sontagfoundation.org/grant_opps/grant_opps_dsa.htm <http://www.sontagfoundation.org/grant_opps/grant_opps_dsa.htm>

American Cancer Society
Miscellaneous funding mechanisms
Deadline:  April 1, 2010 via proposalcentral
http://www.cancer.org/docroot/RES/RES_5_1.asp?sitearea=RES

James S. McDonnell Foundation
Collaborative Activity Award
Letter of intent: accepted any time
Topics:  Complex Systems, Brain Cancer, Human Cognition
multi-institutional, possibly multi-disciplinary, multi-investigator, flexible budget, length flexible
http://www.jsmf.org/apply/collaborative/ <http://www.jsmf.org/apply/collaborative/>

NCMHD Innovative Faith-Based Approaches to Health Disparities Research (R21)
(RFA-MD-10-004)
National Center for Minority Health and Health Disparities
Application Receipt Date(s): March 17, 2010 http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-10-004.html <http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-10-004.html>

FY10 Ovarian Cancer Research Program (OCRP)
Pilot Award
The OCRP Pilot Award supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer forward. Research priorities should include a testable hypothesis based on strong scientific rationale. Successful projects should provide a catalyst to expand or modify current thinking and/or approaches in ovarian cancer research. Preliminary data are not required, but are allowed. The strength of the proposal should be based on sound scientific rationale and logical reasoning. Clinical trials will not be supported by this award mechanism.
Amount of funding:  
Maximum of $200,000 in direct costs (plus indirects) for up to 3 years
Maximum funding of $250,000 for direct costs with a qualified nested Teal Pre-doctoral Scholar** (plus indirect costs).Period of performance not to exceed 2 yrs.
20 pilot award applications will be funded.
Eligibility:  Stanford faculty with PI eligibility
**For applications with an optional nested Teal Pre-doctoral Scholar:
A nested Teal Predoctoral Scholar is defined as a pre-doctoral student who is currently enrolled full time in an accredited doctoral program (e.g., Ph.D., M.D./Ph.D., D.Sc.) and who will have successfully completed comprehensive examinations or otherwise will have met pre-dissertation requirements by time of award.
Deadlines:
Pre-application: March 11, 2010,  5 p.m. EST via the CDMRP eReceipt system

Invitation to Submit an Application: April 2010
Full application (by invitation only):  June 10, 2010 11:59 p.m. EST  via grants.gov

FY10 Prostate Cancer Research Program (PCRP)
Idea Development Award
The PCRP Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to eliminating death and suffering from prostate cancer. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. The PCRP seeks applications from the wide spectrum of basic to clinical research (excluding clinical trials), that are responsive to at least one of the PCRP overarching challenges and at least one of the PCRP focus areas.
See the program guidelines for 2010 research focus areas.
Amount of funding: maximum funding of $450,000 in direct costs (plus indirects) for up to 3 years
Eligibility:  Stanford faculty with PI eligibility
Deadlines:
Pre-application:  March 3, 2010, 5 p.m. EST via the CDMRP eReceipt system

Invitation to Submit an Application: April 21, 2010
Full application (by invitation only):  June 9, 2010 11:59 p.m. EST  via grants.gov

Synergistic Idea Development Award
The PCRP Synergistic Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research involving two or three independent, faculty-level (or equivalent) Principal Investigators (PIs). These investigators should use synergistic and complementary perspectives to address a central problem or question in prostate cancer research. This award is designed to encourage and support both new and pre-existing partnerships. The overall goal of this award is to significantly accelerate advances in prostate cancer research to support the PCRP vision of conquering prostate cancer. 

The Synergistic Idea Development Award requires that multiple investigators jointly design a single project. However, each partner will be recognized as a PI, submit a separate application and receive an individual award. The research project must be supported by the unique expertise of each PI, and it must clearly define the synergistic components that will facilitate and accelerate progress in a way that could not be accomplished through independent efforts. Multidisciplinary projects are encouraged, and multi-institutional projects are allowed.
See the program guidelines for 2010 research focus areas.
Amount of funding: maximum funding of $750,000 in direct costs (plus indirects) for up to 3 years
Eligibility:  Stanford faculty with PI eligibility
Deadlines:
Pre-application:  March 3, 2010,  5 p.m. EST via the CDMRP eReceipt system

Invitation to Submit an Application: April 21, 2010
Full application (by invitation only):  June 9, 2010 11:59 p.m. EST  via grants.gov

Small Grants Program for Cancer Epidemiology (R03) PAR-08-237
Application Due Date(s): March 19, 2010; July 23, 2010; Nov. 19, 2010; March 18, 2011; July 22, 2011; Nov. 18, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-08-237.html

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) PAR-09-160
Application Receipt Date(s): June 23, 2010; Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-160.html

Translational Tools for Clinical Studies of CAM Interventions (R01)
(RFA-AT-10-001)
National Center for Complementary and Alternative Medicine
Letters of Intent Receipt Date(s): Not Applicable
Application Receipt Date(s): March 23, 2010
http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-10-001.html

Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01)
(PA-10-025)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Standard R01 deadlines:  Feb. 5; June 5; Oct. 5
Standard AIDS- AIDS-related deadlines: Jan. 7; May 7; Sept. 7
http://grants.nih.gov/grants/guide/pa-files/PA-10-025.html

Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21)
(PA-10-026)
National Cancer Institute
Application Receipt/Submission Date(s):Multiple dates, see announcement.
Exploratory/developmental (R21) grant mechanism
Standard R21 deadlines: Feb. 16; June 16; Oct. 16
Standard AIDS- AIDS-related deadlines: Jan. 7; May 7; Sept. 7
http://grants.nih.gov/grants/guide/pa-files/PA-10-026.html

Howard Hughes Medical Institute (HHMI)
Unlimited applicants are permitted.

You may apply to both the HHMI/NIH Research Scholars Program and the HHMI Research Training Fellowships for Medical Students in a given year. You may also apply to other NIH programs.

Epigenetic Approaches in Cancer Epidemiology (R01)
(PA-10-031)
National Cancer Institute
Application Receipt/Submission Date(s):  Multiple dates, see announcement.
Standard R01 deadlines: Feb. 5; June 5; Oct. 5
http://grants.nih.gov/grants/guide/pa-files/PA-10-031.html

Epigenetic Approaches in Cancer Epidemiology (R21)
(PA-10-032)
National Cancer Institute
Application Receipt/Submission Date(s):  Multiple dates.

Cancer Prevention Research Small Grant Program (R03)
The NCI invites applications that propose small and time-limitedprojects pertinent to the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, and/or clinical prevention studies that focus on specific target organs.
Letter of intent: not applicable
Deadline:  March 19, 2010, via grants.gov*
http://grants.nih.gov/grants/guide/pa-files/PAR-08-055.html

Small Grants for Behavioral Research in Cancer Control (R03) PAR-09-003
Eligibility:  Stanford faculty with PI eligibility
Letter of intent:  not applicable
Deadline:  April 20, 2010, via grants.gov*
http://grants.nih.gov/grants/guide/pa-files/PAR-09-003.html

Small Grants for Behavioral Research in Cancer Control (R03) PAR-09-003
Application Due Date(s): April 20, 2010; Aug. 20, 2010; Dec. 20, 2010; April 20, 2011; Aug. 22, 2011; Dec. 20, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-003.html

Small Grants Program for Cancer Epidemiology (R03) PAR-08-237
Application Due Date(s): March 19, 2010; July 23 ,2010; Nov. 19, 2010; March 18, 2011; July 22, 2011; Nov. 18, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-08-237.html

Alphabetical List of Other NCI Funding Opportunities

Academic-Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01)
PAR-07-214

Remaining Application Submission/Receipt Date(s):  Feb. 5, 2010
Expiration Date: March 6, 2010
http://grants.nih.gov/grants/guide/pa-files/PAR-07-214.html

Basic Cancer Research in Cancer Health Disparities (U01) PAR-09-161
Letters of Intent Receipt Date(s): Not Applicable
Application Receipt Date(s): June 23, 2010; Nov. 23, 2010; June 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-161.html

Biomarkers for Early Detection of Hematopoietic Malignancies (R01) PA-09-197
Standard R01

Application Submission/Receipt Date(s) apply:  Feb. 5; June 5; Oct. 5
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-197.html

Biomarkers for Early Detection of Hematopoietic Malignancies (R21)  PA-09-198
Standard R01

Application Submission/Receipt Date(s) apply:  Feb. 16; June 16; Oct. 16
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-198.html

Cancer Surveillance Using Health Claims-based Data System (R03)
PA-09-143

Standard R03
Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-143.html

Cancer Surveillance Using Health Claims-based Data System (R03) PA-09-144
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-144.html

Cancer Surveillance Using Health Claims-based Data System (R03) PA-09-145
Standard R01

Application Submission/Receipt Date(s): Feb. 5; June 5; Oct. 5
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-145.html

Clinical Cancer Therapy and Prevention Research (R01) PA-07-356
Remaining Application Submission/Receipt Date(s):  Feb. 5, 2010
Expiration/Closing Date: May 8, 2010
http://grants.nih.gov/grants/guide/pa-files/PA-07-356.htm

Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) PAR-09-026
Letters of Intent Receipt Dates: Jan. 19, 2010; Sept. 19, 2010; Jan. 18, 2011; Sept. 19, 2011.
Application Due Dates:  Feb. 19, 2010; Oct. 19, 2010; Feb.18, 2011; Oct. 19, 2011.
http://grants.nih.gov/grants/guide/pa-files/PAR-09-026.html

Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01) PA-10-025
Standard R01 Application

Submission/Receipt Date(s): Feb. 5; June 5; Oct. 5
Expiration Date: Jan. 8, 2013
http://grants.nih.gov/grants/guide/pa-files/PA-10-025.html

Development, Application, and Evaluation of Prediction Models for
Cancer Risk and Prognosis (R21) PA-10-026
NIH Exploratory/Developmental (R21) grant mechanism

Standard R21 Application
Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: Jan. 8, 2013
http://grants.nih.gov/grants/guide/pa-files/PA-10-026.html

Developmental Projects in Complementary Approaches to Cancer Care and Treatment (R21) PA-09-167
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21
Application
Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-167.html

Developmental Projects in Complementary Approaches to Cancer Care and
Treatment (R03) PA-09-168
Standard R03 Application

Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-168.html

Developmental Research in Cancer Prognosis and Prediction (R21) PA-09-158
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21
Application Submission/Receipt Date(s): Feb. 16, June 16, Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-158.html

Developmental Research in Cancer Prognosis and Prediction (R33) PA-09-159
NIH Exploratory/Developmental Phase II Research Grant (R33 Standard R33
)
Application Submission/Receipt Date(s): Feb. 16 June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-159.html

Diet, Epigenetic Events and Cancer Prevention (R01) PA-09-234
Standard R01

Application Submission/Receipt Date(s): Feb. 5; June 5; Oct. 5
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-234.html

Diet, Epigenetic Events and Cancer Prevention (R21) PA-09-235
NIH Exploratory/Developmental (R21) grant mechanism

Standard R21 Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-235.html

Diet-Induced Changes in Inflammation as Determinants of Colon Cancer
(R01) PA-08-210
Standard R01

Application Submission/Receipt Date(s): Feb. 5; June 5; Oct. 5
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-210.html

Diet-Induced Changes in Inflammation as Determinants of Colon Cancer
(R21) PA-08-211
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-211.htm

Epigenetic Approaches in Cancer Epidemiology (R01) PA-10-031
Standard R01

Application Submission/Receipt Date(s): Feb. 5; June 5; Oct. 5
Expiration Date: Jan. 8, 2013
http://grants.nih.gov/grants/guide/pa-files/PA-10-031.html

Epigenetic Approaches in Cancer Epidemiology (R21) PA-10-032
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: Jan. 8, 2013
http://grants.nih.gov/grants/guide/pa-files/PA-10-032.html

Erythropoiesis Stimulating Agents and Tumor Progression (R01) PA-09-023
Standard R01

Application Submission/Receipt Date(s): Feb. 5; June 5; Oct. 5
Expiration Date: Jan. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-023.html

Erythropoiesis Stimulating Agents and Tumor Progression (R21) PA-09-024
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): Feb. 1;, June 16; Oct. 16
Expiration Date: Jan. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-024.html

Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01)
PAR-09-147

The primary focus of the proposed projects must be on the basic biology, prevention, and/or treatment of liver cancer.
Letters of Intent Receipt Date(s): Dec. 28, 2009; April 28, 2010; Aug. 28, 2010; Dec. 28, 2010; and April 27, 2011
Application Due Date(s): Jan. 28, 2010; May 28, 2010; Sept. 28, 2010; Jan. 28, 2011; and May 27, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-147.html

Etiology, Prevention and Treatment of Hepatocellular Carcinoma (R01) PA-08-243
Standard R01

Application Submission/Receipt Date(s) apply:  Feb. 5; June 5; Oct. 5
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-243.htm

Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R21) PA-08-244
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-244.html

Exfoliated Cells and Circulating DNA in Cancer Detection and
Diagnosis (R21) PA-09-238
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-238.html

Exploratory Cancer Prevention Studies Involving Molecular Targets for
Bioactive Food Components (R21) PA-07-362NCI, NIA, ODS

Remaining Application Submission/Receipt Date(s): Feb. 16, 2010
Expiration Date: March 17, 2010
http://grants.nih.gov/grants/guide/pa-files/PA-07-362.html

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) PAR-09-160
Letters of Intent Receipt Date: Not Applicable
Application Receipt Date(s): June 23, 2009; Nov. 23, 2009; June 23, 2010; Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-160.html

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) PAR-09-162
Letters of Intent Receipt Date(s): Oct. 23, 2009; May 23, 2010; Oct. 23, 2010; May 23, 2011; Oct. 23, 2011
Application Due Date(s): Nov. 23, 2009; June 23, 2010, Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-162.html

Exploratory Grants for Behavioral Research in Cancer Control (R21) PA-09-130
Standard R21

Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-130.html

Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) PA-08-267
Standard R21

Application Submission/Receipt Date(s): Feb. 16; June 16; Oct. 16
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-08-267.html

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) PAR-09-160
Application Receipt Date(s): June 23, 2010; Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-160.html

Basic Cancer Research in Cancer Health Disparities (U01) PAR-09-161
Application Receipt Date(s): Nov. 23, 2009; June 23, 2010; Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-161.html

Geographic and Contextual Influences on Energy Balance-Related Health Behaviors (R01) PA-08-192 NCI, NHLBI, NINR, NICHD, OBSSR
Standard R01

Application Submission/Receipt Date(s) apply:  Feb. 5; June 5; Oct. 5
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-192.htm

Geographic and Contextual Influences on Energy Balance-Related Health Behaviors (R21) PA-08-193 NCI, NHLBI, NINR, NICHD, OBSSR
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s) apply:  Feb. 16; June 16; Oct. 16 Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-193.html

Stanford-NIH K Award Resource Webpage
http://ora.stanford.edu/grantsgov/nih_k_award.asp
This webpage was developed by Lisa Forgatsch in the Office of Research Administration and contains specific support materials for your NIH Grants.gov K award proposals, including application tools, NIH e Commons User name, training and protocol resources, software resources, online materials, required forms.
 
NIH K Award Kiosk
List of available K award mechanisms**
http://grants.nih.gov/training/careerdevelopmentawards.htm

Additional K award information for postdoctoral fellows:
http://med.stanford.edu/rmg/fellowships.html#kawards

Grants.gov@Stanford resources Setting up your computer, eSubmit, etc.
http://ora.stanford.edu/grantsgov/default.asp

NIH Guide Funding Opportunity Search Tool
http://grants.nih.gov/grants/guide/

New Investigator Guide to NIH funding
(A NIAID tool for all investigators)
http://www.niaid.nih.gov/ncn/grants/new/default.htm

RMG Funding Information Web Resources webpage
http://med.stanford.edu/rmg/funding/

 

 

Stanford Medicine Resources:

Footer Links: